ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
1-Year Return
169.78%
This Quarter Return
+27.06%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$477M
AUM Growth
+$74.3M
(+18%)
Cap. Flow
+$20.7M
Cap. Flow
% of AUM
4.34%
Top 10 Holdings %
Top 10 Hldgs %
81.11%
Holding
86
New
9
Increased
11
Reduced
4
Closed
11
Top Buys
| 1 |
Gyre Therapeutics
GYRE
|
+$18.2M |
| 2 |
Arrowhead Research
ARWR
|
+$12.7M |
| 3 |
Tandem Diabetes Care
TNDM
|
+$6.68M |
| 4 |
Rocket Pharmaceuticals
RCKT
|
+$6.56M |
| 5 |
argenx
ARGX
|
+$6.5M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$13.1M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$12M |
| 3 |
PDS Biotechnology
PDSB
|
+$8.84M |
| 4 |
Evolent Health
EVH
|
+$5.17M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
+$4.42M |
Sector Composition
| 1 | Healthcare | 78.81% |
| 2 | Communication Services | 0% |
| 3 | Technology | 0% |
